NICOLE HILL: Open Payments
NPI 1235716697 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,339 in 102 payments from 20 companies in 2025. Trend: 2023 $2,502 · 2024 $3,780 · 2025 $2,339
Food & beverage: $2,339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $368 |
| Otsuka America Pharmaceutical, Inc. | 14 | $328 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $231 |
| Janssen Pharmaceuticals, Inc | 5 | $204 |
| Alkermes, Inc. | 8 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $162 |
| REVANCE THERAPEUTICS, INC. | 1 | $146 |
| Vanda Pharmaceuticals Inc. | 11 | $135 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| Supernus Pharmaceuticals, Inc. | 10 | $115 |
Products named: VRAYLAR, REXULTI, CAPLYTA, SPRAVATO, TRINTELLIX, DAXXIFY, ARISTADA, FANAPT.
Industry payments across FL — which companies pay providers there.
